<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS98602</article-id>
<article-id pub-id-type="doi">10.1101/2020.10.13.337212</article-id>
<article-id pub-id-type="archive">PPR226630</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>SARS-CoV-2 S protein ACE2 interaction reveals novel allosteric targets</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Raghuvamsi</surname>
<given-names>Palur</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Tulsian</surname>
<given-names>Nikhil</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Samsudin</surname>
<given-names>Firdaus</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qian</surname>
<given-names>Xinlei</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Purushotorman</surname>
<given-names>Kiren</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yue</surname>
<given-names>Gu</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kozma</surname>
<given-names>Mary</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lescar</surname>
<given-names>Julien</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bond</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>MacAry</surname>
<given-names>Paul</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anand</surname>
<given-names>Ganesh</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, Singapore 117543</aff>
<aff id="A2">
<label>2</label>Department of Biochemistry, National University of Singapore, 28 Medical Drive, Singapore 117546</aff>
<aff id="A3">
<label>3</label>Bioinformatics Institute, Agency for Science, Technology, and Research (A*STAR), 30 Biopolis Street, Singapore 138671</aff>
<aff id="A4">
<label>4</label>Life Sciences Institute, Centre for Life Sciences, National University of Singapore, 28 Medical Drive, Singapore 117546</aff>
<aff id="A5">
<label>5</label>School of Biological Sciences, National Technological University, 60 Nanyang Drive, Singapore 637551</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>Correspondence: <email>dbsgsa@nus.edu.sg</email>, <email>micpam@nus.edu.sg</email>, <email>peterjb@bii.a-star.edu.sg</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>10</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>16</day>
<month>10</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">The Spike (S) protein is the main handle for SARS-CoV-2 to enter host cells through surface ACE2 receptors. How ACE2 binding activates proteolysis of S protein is unknown. Here, we have mapped the S:ACE2 interface and uncovered long-range allosteric propagation of ACE2 binding to sites critical for viral host entry. Unexpectedly, ACE2 binding enhances dynamics at a distal S1/S2 cleavage site and flanking protease docking site ~27 Å away while dampening dynamics of the stalk hinge (central helix and heptad repeat) regions ~ 130 Å away. This highlights that the stalk and proteolysis sites of the S protein are dynamic hotspots in the pre-fusion state. Our findings provide a mechanistic basis for S:ACE2 complex formation, critical for proteolytic processing and viral-host membrane fusion and highlight protease docking sites flanking the S1/S2 cleavage site, fusion peptide and heptad repeat 1 (HR1) as allosterically exposed cryptic hotspots for potential therapeutic development.</p>
</abstract>
<kwd-group>
<kwd>Spike</kwd>
<kwd>ACE2</kwd>
<kwd>allostery</kwd>
<kwd>proteolysis</kwd>
<kwd>virus-host interactions</kwd>
<kwd>fusion peptide</kwd>
<kwd>SARS-CoV-2</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p id="P2">The COVID-19 pandemic caused by the SARS-CoV-2 virus has sparked extensive efforts to map molecular details of its life cycle to drive vaccine and therapeutic discovery.(<xref ref-type="bibr" rid="R1">1</xref>) SARS-CoV-2 belongs to the family of <italic>Coronaviridae</italic> which includes other human pathogens including common cold causing viruses (hCoV-OC43, HKU and 229E), SARS and MERS-CoV.(<xref ref-type="bibr" rid="R2">2</xref>–<xref ref-type="bibr" rid="R5">5</xref>) SARS-CoV-2 has a ~30 Kbp long positive RNA genome with 14 open reading frames, encoding 4 structural proteins: Spike (S) protein, membrane (M) protein, envelope (E) protein and nucleo-protein; 16 non-structural proteins and 9 accessory proteins.(<xref ref-type="bibr" rid="R6">6</xref>–<xref ref-type="bibr" rid="R8">8</xref>) An intact SARS-CoV-2 virion consists of a nucleocapsid core composed of nucleoprotein packaged genomic RNA encapsidated as a lipid-protein envelope forming a spherical structure of diameter ~100 nm.(<xref ref-type="bibr" rid="R9">9</xref>) The viral envelope is decorated with S, M and E proteins.(<xref ref-type="bibr" rid="R9">9</xref>) The S protein is a club-shaped homotrimeric class I viral fusion protein that has distinctive ‘head’ and ‘stalk’ regions (<xref ref-type="fig" rid="F1">Fig. 1A</xref>).</p>
<p id="P3">A characteristic feature of SARS-CoV-2 is proteolysis of Pre-fusion S protein by host proteases into S1 and S2 subunits. The S1 subunit comprises an N-terminal domain (NTD) and a receptor binding domain (RBD) that interacts with the host receptor Angiotensin converting enzyme-2 (ACE2)(<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R11">11</xref>) to initiate viral entry into the host.(<xref ref-type="bibr" rid="R12">12</xref>) Cryo-electron tomography (cryo-ET) has been used to capture the distribution and organization of trimeric S protein on the intact virion,(<xref ref-type="bibr" rid="R9">9</xref>) revealing that 25 ± 9 S protein trimers decorate a single virion with a small percentage (3%) of embedded S proteins in a post-fusion state adopting an extended helical conformation. The first virus-host interaction is mediated by the viral S protein with the host ACE2 receptor.(<xref ref-type="bibr" rid="R10">10</xref>) Binding to ACE2 primes the S protein for proteolysis at S1/S2 cleavage site into individual S1 and S2 subunits.(<xref ref-type="bibr" rid="R13">13</xref>, <xref ref-type="bibr" rid="R14">14</xref>) The S2 subunit is divided into six constituent domains harboring the membrane fusion machinery of the virus. These comprise the fusion peptide (FP), heptad repeat (HR1), heptad repeat 2 (HR2), connector domain (CD), transmembrane domain (TM), and cytoplasmic tail (CT).(<xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R16">16</xref>) Extensive structural studies (<xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R17">17</xref>, <xref ref-type="bibr" rid="R18">18</xref>) have captured S proteins of coronaviruses in distinct open- (PDB:6VXX)(<xref ref-type="bibr" rid="R15">15</xref>) and closed- (PDB:6VYB)(<xref ref-type="bibr" rid="R15">15</xref>) conformational states with regards the RBD, as well as the ectodomain orientation in the pre- and post-fusion states, thereby revealing a high intrinsic metastability of the S protein. The S2 subunit promotes membrane fusion and viral entry (<xref ref-type="fig" rid="F1">Fig. 1B</xref>).</p>
<p id="P4">Despite extensive cryo-EM studies, how ACE2 binding at the RBD domain primes enhanced proteolytic processing at the S1/S2 site is entirely unknown. Amide hydrogen/deuterium exchange mass spectrometry (HDXMS) is a powerful complementary tool for both virus dynamics (<xref ref-type="bibr" rid="R19">19</xref>) and mapping protein-protein interactions.(<xref ref-type="bibr" rid="R20">20</xref>) Here, we describe the dynamics of free S protein, the S:ACE2 complex and describe ACE2 binding-induced allosteric conformational changes across the distal regions of S protein, particularly at the stalk and protease docking sites flanking the S1/S2 cleavage sites. These distal ‘hotspots’ are critical for the first step of SARS-CoV-2 infection and represent novel targets for therapeutic intervention.</p>
<sec id="S1" sec-type="results | discussion">
<title>Results and Discussion</title>
<sec id="S2">
<title>Localizing subunit specific dynamics and domain motions of S protein trimer</title>
<p id="P5">Structural snapshots of the ACE2 binding to the SARS-CoV-2 S protein interface have been obtained with the RBD alone.(<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R21">21</xref>–<xref ref-type="bibr" rid="R23">23</xref>) In this study, we have mapped this interface for the S protein construct (1-1208) with mutations at the S1/S2 cleavage site (PRRAS to PGSAS) and proline substitution at 986-987,(<xref ref-type="bibr" rid="R16">16</xref>) to block proteolysis during expression and purification (<xref ref-type="supplementary-material" rid="SD1">Fig. S1A</xref>). The S protein and isolated RBD constructs showed high affinity binding to ACE2 (<xref ref-type="supplementary-material" rid="SD1">Fig. S1B</xref>). We measured dynamics of a trimer of this near-full length S protein by amide hydrogen-deuterium exchange mass spectrometry (HDXMS). Pepsin proteolysis generated 321 peptides with high signal to noise ratio, accounting for ~87% of the entire S protein (<xref ref-type="supplementary-material" rid="SD1">Fig. S2</xref>). Glycosylation of at least 22 sites have been predicted on S protein.(<xref ref-type="bibr" rid="R24">24</xref>) Average deuterium exchange at these reporter peptides was monitored for comparative deuterium exchange analysis of S protein, ACE2 receptor and S:ACE2 complex, along with a specific ACE2 complex with the isolated RBD. While glycosylation is an important posttranslational modification, our HDXMS study has measured deuterium exchange of non-glycosylated segments of S protein alone. Deuterium exchange (t = 1 and 10 min) across all peptides of the free S protein trimer are shown in (<xref ref-type="fig" rid="F2">Fig. 2</xref>). We built an integrative model of the full-length S protein trimer using experimental structures of prefusion S ectodomain in the open conformation (PDB: 6VSB)(<xref ref-type="bibr" rid="R16">16</xref>) and the HR2 domain from SARS S protein as templates. Mapping the relative deuterium exchange across all peptides onto this S protein model showed the greatest deuterium exchange at the stalk region. (<xref ref-type="fig" rid="F2">Fig. 2A</xref>) This is consistent with earlier studies showing at least 60° sweeping motions of the three identified hinge regions of the stalk.(<xref ref-type="bibr" rid="R18">18</xref>) This was further verified via all-atom MD simulations of the S protein model embedded in a viral model membrane, which showed significant motions of the S protein ectodomain as a result of the flexible stalk region, (<xref ref-type="fig" rid="F2">Fig. 2B</xref>) as well as large atomic fluctuations around the HR2 domain, compared to the rest of the protein (<xref ref-type="supplementary-material" rid="SD1">Fig. S3, Fig. S4</xref>).</p>
<p id="P6">The deuterium exchange heat map showed the highest relative exchange in the S2 subunit (<xref ref-type="supplementary-material" rid="SD1">Fig. S3</xref>) and helical segments, while peptides spanning the fusion peptide showed relatively lower deuterium exchange. Individually, S1 and S2 subunits showed different intrinsic deuterium exchange kinetics, where the average relative fractional deuterium uptake (RFU) of S1 subunit (~0.25) was lower than the average RFU (~0.35) of S2 subunit (<xref ref-type="supplementary-material" rid="SD1">Fig. S3, Table S1</xref>). Moreover, peptides connecting the RBD to the remainder of the S protein showed greater deuterium exchange, reflecting its role as a ‘hinge’ facilitating the RBD populating an ensemble of open- and closed-conformational states (red arrow, <xref ref-type="fig" rid="F2">Fig. 2C</xref>). Indeed, in our simulations of the S protein (<xref ref-type="fig" rid="F2">Fig. 2B</xref>), the RBD oriented initially in an ‘up’- conformation exhibited spontaneous motion towards the ‘down’-conformation relative to the hinge region (<xref ref-type="fig" rid="F2">Fig. 2D</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S4A</xref>). Interestingly, a part of the receptor binding motif, specifically residues 476-486, exhibited a higher degree of flexibility based on its average atomic fluctuations (<xref ref-type="fig" rid="F2">Fig. 2A, 4C</xref>), suggesting that binding to ACE2 receptor would be required to stabilize its motion.</p>
<p id="P7">The NTD of the S protein showed low overall RFU (~0.2), consistent with its well-structured arrangement of β-sheets connected by loops (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). Importantly, certain regions showed significantly higher deuterium exchange (~0.4), of which two loci (136-143, 243-265) span the dynamic interdomain interactions with the RBD. This is supported by the high per-residue root mean square fluctuations (RMSF) and large principal motions observed for residues 249-259 during simulations (<xref ref-type="fig" rid="F2">Fig. 2C</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S4C</xref>). One locus (291-303) at the C-terminal end of the NTD connecting to the RBD showed high deuterium exchange, indicative of relative motions of the two domains. The RBD (<xref ref-type="fig" rid="F1">Fig. 1D</xref>) showed relatively higher deuterium exchange (RFU ~0.35), with the peptides spanning the hinge-regions (318-336) showing greatest deuterium exchange (~0.6). Peptides spanning residues 351-375 and 432-452 showed significantly increased deuterium uptake, and these correspond to the NTD interdomain interaction sites. Interestingly, loci of the RBD implicated in the interface (453-467, 491-510) with ACE2 showed relative higher exchange.</p>
<p id="P8">Overall, the S2 subunit showed relatively higher RFU than the S1 subunit, with each domain exhibiting specific conformational changes (<xref ref-type="fig" rid="F1">Fig. 1E</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S4</xref>). Peptides spanning the region immediately downstream of the S1/S2 cleavage site showed the highest deuterium uptake (0.6), reflecting the rapid dynamics it undergoes for facilitating cleavage of S protein into two subunits. Congruently, our MD simulations revealed the unstructured loop housing the S1/S2 cleavage site (residues 677-689) to be highly dynamic (Figure S4C), with RMSFs reaching &gt;1.0 nm. It is important to note that the S1/S2 cleavage site has been abrogated in the construct of the S protein used in this study to block proteolytic processing into S1 and S2 subunits during expression in host cells. We thus observed lower deuterium uptake (and lower RMSF values) at peptides in the central helix and connector domain, suggesting that these act as the central core of prefusion S, while the peptides spanning hinge-segments and heptad repeats (HR1 and HR2) showed high deuterium uptake and RMSF values, indicative of the inherent metastability of S to adopt prefusion, fusion and post-fusion conformations.</p>
</sec>
<sec id="S3">
<title>Domain-specific and global effects of ACE2 binding to the RBD</title>
<p id="P9">Comparative HDXMS analysis of the S protein and S:ACE2 complex revealed large-scale effects upon binding of ACE2. The main target for direct interactions was the RBD. We therefore set out to characterize the effects of ACE2 binding with RBD (‘RBD<sub>S</sub>’) present on full S protein (<xref ref-type="fig" rid="F4">Fig. 4A, 4B</xref>) and compared this to an isolated construct of the RBD (‘RBD<sub>isolated</sub>’) (<xref ref-type="fig" rid="F3">Fig. 3</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S6</xref>). Several peptides of the RBD<sub>S</sub> showed decreased exchange upon complexation with ACE2 (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). These include peptides 340-359, 400-420, 432-452 and 487-502 in the RBD<sub>S</sub>:ACE2 complex (<xref ref-type="fig" rid="F4">Fig. 4</xref>). These sites are consistent with the interface of the SARS-CoV-2 S protein RBD bound to the ACE2 receptor resolved by X-ray crystallography.(<xref ref-type="bibr" rid="R10">10</xref>) The high-resolution structures showed that the RBD and ACE2 receptor interact via an extensive interface. However, not all peptides at the interface contribute equally to the binding energetics. HDXMS reveals the residues at the core of this interface to be those within peptides spanning residues 340-359, 400-420, 432-452 and 491-510 (<xref ref-type="fig" rid="F4">Fig. 4A, 4D</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S3</xref>). Interestingly, loci showing large-magnitude deuterium exchange correlate to mutational hotspots(<xref ref-type="bibr" rid="R25">25</xref>).</p>
<p id="P10">A close-up of RBD<sub>isolated</sub>:ACE2 complex also showed decreased exchange in peptides spanning these regions (<xref ref-type="fig" rid="F3">Fig. 3</xref>). However, the magnitude of decrease in exchange was significantly greater in RBD<sub>isolated</sub> than in RBD<sub>S</sub>, indicating the higher flexibility in the full-length S trimer than in free RBD. High resolution structures have identified the RBD interface interacting with ACE2 spanning the peptide covering residues 448-501 (Y449, Y453, N487, Y489, G496, T500, G502, Y505, L455, F456, F486, Q493, Q498 and N501) using only the RBD from the S protein.(<xref ref-type="bibr" rid="R23">23</xref>) Cryo-EM studies have shown that each RBD in the trimeric S protein can adopt an open conformation irrespective of other RBDs, indicating an absence of cooperativity between the three RBDs within a trimer.(<xref ref-type="bibr" rid="R9">9</xref>) Therefore, we compared the deuterium exchange profiles of RBD<sub>isolated</sub> with RBD<sub>S</sub> and observed differences in dynamics imposed by quaternary contacts (<xref ref-type="fig" rid="F3">Fig. 3A</xref>, <xref ref-type="fig" rid="F3">Fig. 3B</xref>). Overall, the loci with high and low deuterium exchange profiles were similar when compared between RBD<sub>isolated</sub> and RBD<sub>S</sub>, both at the disordered ACE2 receptor binding region as well as the folded region at the N- and C -termini. In solution RBD<sub>S</sub> toggles between open- and closed-conformations resulting in an average readout of deuterium exchange measurements.</p>
<p id="P11">ACE2 binding to RBD<sub>isolated</sub> and RBD<sub>S</sub> resulted in similar effects, where we observed deuterium exchange protection at the peptide regions spanning the known binding interface of RBD. Notably, increased deuterium exchange was observed at the hinge region (<xref ref-type="fig" rid="F3">Fig. 3C</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S4</xref>) indicating allosteric conformational changes, associated with restricting the open- and closed-states interconversion. Therefore, the destabilization/ local unfolding observed at the hinge region as a result of ACE2 binding enables RBD to maintain open conformation. It therefore seems likely that small molecules and biologics targeting the hinge region to lock RBD in the closed state would be of potential high therapeutic value.</p>
</sec>
<sec id="S4">
<title>ACE2 binding at the RBD is allosterically propagated to the S1/S2 cleavage site and Heptad Repeat</title>
<p id="P12">Unexpectedly, ACE2 binding at the RBD induced large-scale changes in deuterium exchange in distal regions of the S protein. Some of the peptides in the stalk of S protein showed decreased exchange in the S:ACE2 complex (<xref ref-type="fig" rid="F4">Fig. 4C, 4D</xref>). This indicates that ACE2 receptor interactions stabilized the hinge dynamics. Decreased exchange was also seen in the distal sites in the S2 subunit, localized at the fusion peptide locus and central helix (CH). Interestingly, increased exchange was seen in multiple peptides flanking the S1/S2 cleavage site, HR1 domain and critically at the S1/S2 cleavage sites (<xref ref-type="fig" rid="F4">Fig. 4D</xref>). Even though the construct used in this study has the proteolysis site mutated, it still resulted in increased dynamics at this S1/S2 locus. Furthermore, this region exhibited high RMSF values during simulations. (<xref ref-type="supplementary-material" rid="SD1">Fig. S4B</xref>). These results clearly indicate that ACE2 binding induces allosteric enhancement of dynamics at this locus, providing mechanistic insights into the conformational switch from the pre-fusion to fusogenic intermediate. Differences in deuterium exchange between free S protein and S:ACE2 complex shows stabilization at ACE2 interacting site and local destabilization at peptides juxtaposed to S1/S2 cleavage site (residues 931-938). This suggests that ACE2 binding potentiates peptide of residues 931-938 and other high exchanging regions flanking the S1/S2 cleavage site for enhanced furin protease binding and cleavage. Importantly, these results suggest that the S1/S2 cleavage site is a critical hotspot for S protein dynamic transitions for viral entry into the host, and therefore represents a new target for inhibitory therapeutics against the virus.</p>
</sec>
<sec id="S5">
<title>Dynamics of ACE2 with RBD and S protein provides insights into viral-entry into host</title>
<p id="P13">Considering the indispensable role of ACE2 binding in SARS-CoV-2 infection, it is crucial to assess the effects of S protein and RBD binding on ACE2 dynamics. We therefore mapped the corresponding binding sites of RBD, both isolated and within the Spike, on ACE2. The S:ACE2 complex represents the prefusion pre-cleavage state wherein full-length S protein is bound to the ACE2 receptor (<xref ref-type="fig" rid="F1">Fig. 1B ii</xref>), while the RBD<sub>isolated</sub>:ACE2 complex represents the post-furin cleavage product formed by the S1 subunit and ACE2 (<xref ref-type="fig" rid="F1">Fig. 1B iii</xref>). Previous studies have shown that 14 key amino acids of RBD interact with ACE2, wherein mutations at 6 amino acids resulted in higher binding affinity of SARS-CoV-2.(<xref ref-type="bibr" rid="R26">26</xref>) SARS-CoV-2 adopted a different binding mode to ACE2 as a superior strategy for infection in comparison to SARS-CoV-1. A crystal structure of RBD<sub>isolated</sub>:ACE2 complex has identified 24 key ACE2 residues, spanning across peptides 16-45, 79-83, 325-330, 350-357 and Arg393.(<xref ref-type="bibr" rid="R27">27</xref>) While most of these residues are conserved in binding to both SARS-CoV-1 and SARS-CoV-2, Arg393 and residues 325-330 are unique to SARS-CoV-1 interaction.(<xref ref-type="bibr" rid="R25">25</xref>) Interestingly, we observed increased deuterium exchange at these residues in the S:ACE2 complex compared to ACE2 alone (<xref ref-type="supplementary-material" rid="SD1">Fig. S8</xref>). Identifying the intrinsic dynamics and allosteric changes due to binding could potentially better inform drug development.</p>
<p id="P14">Simulations of the ACE2 dimer complexed with the B<sup>0</sup>AT1 amino acid transporter (PDB: 6M1D)(<xref ref-type="bibr" rid="R12">12</xref>) in a model epithelial membrane revealed a large motion of the peptidase domain (PD), which recognizes the S protein RBD, with respect to the transmembrane and juxtamembrane domains (<xref ref-type="supplementary-material" rid="SD1">Fig. S7</xref>). This large motion is reminiscent of the flexible tilting displayed by the S protein ectodomain itself, suggesting that both S protein and ACE2 have adaptable hinges that allow for orientational freedom of the domains involved in recognition. To understand how S protein binding affects ACE2 dynamics, we performed HDXMS experiments of monomeric ACE2 alone, S:ACE2 and RBD:ACE2 complexes (<xref ref-type="supplementary-material" rid="SD1">Fig. S7, Fig. S8</xref>) and mapped the deuterium exchange values on a deletion construct of ACE2 (PDB: 1R42)(<xref ref-type="bibr" rid="R27">27</xref>) (<xref ref-type="supplementary-material" rid="SD1">Fig. S7, Fig. S8</xref>). We observed a reduction in deuterium exchange across both RBD<sub>isolate</sub>:ACE2 and larger S:ACE2 complexes compared to free ACE2 (Figure S8B and S8C). Differences in deuterium exchange between RBD<sub>isolated</sub>:ACE2 complex and free ACE2 showed that RBD binding stabilizes ACE2 globally, specifically large differences at the binding site (peptides 21-29, 30-39, and 75-92), and also at distal regions (peptides 121-146, 278-292, 575-586) from RBD binding site of ACE2 (<xref ref-type="supplementary-material" rid="SD1">Fig. S8D</xref>). Cryo-EM studies have shown that a dimeric full length ACE2 receptor can stably bind to one trimer of the S protein.(<xref ref-type="bibr" rid="R12">12</xref>)</p>
</sec>
</sec>
<sec id="S6" sec-type="conclusions">
<title>Conclusions</title>
<p id="P15">Here a combination of HDXMS and MD simulations provide a close-up of S protein dynamics in the pre-fusion, ACE2 bound and other associated conformations. Our results reveal the energetics of the S:ACE2 complex interface. ACE2 binding to the isolated RBD and S protein alike lead to binding and stabilization. Interestingly, ACE2 binding to the RBD induces global conformational changes across the entire S protein. Importantly, the stalk region undergoes dampening of conformational motions while causing increased deuterium exchange in the protease sites. Regions highlighting the allosteric propagation of ACE2 binding represent cryptic targets for small molecule inhibitor/antibody development as therapeutics.</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material Legends</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary Materials</label>
<media xlink:href="EMS98602-supplement-Supplementary_Materials.pdf" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="N66374" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S7">
<title>Acknowledgments</title>
<p>We thank Dr. Lu Gan, Dept. of Biological Sciences, National University of Singapore for helpful discussions. We thank Protein Production Platform of Nanyang Technological University for their help in making the RBD and ACE2 expression constructs and small-scale protein expression tests. HDXMS experiments were carried out as a fee for service at the Singapore National Laboratory for Mass Spectrometry (SingMass) funded by NRF, Singapore. P.V.R. was supported by research scholarship from National University of Singapore, Singapore. N.K.T. was supported by research grant from Ministry of Education, Singapore awarded to G.S.A. (MOE2017-T2-A40-112). This work was supported by BII of A*STAR. Simulations were performed on the petascale computer cluster ASPIRE-1 at the National Supercomputing Centre of Singapore (NSCC) and the A*STAR Computational Resource Centre (A*CRC).</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>HDXMS</term>
<def>
<p>Hydrogen Deuterium Exchange Mass Spectrometry</p>
</def>
</def-item>
<def-item>
<term>MD</term>
<def>
<p>molecular dynamics</p>
</def>
</def-item>
<def-item>
<term>RFU</term>
<def>
<p>Relative Fractional deuterium uptake</p>
</def>
</def-item>
<def-item>
<term>RMSF</term>
<def>
<p>root mean squared fluctuations</p>
</def>
</def-item>
<def-item>
<term>PCA</term>
<def>
<p>Principal Component Analysis</p>
</def>
</def-item>
<def-item>
<term>S</term>
<def>
<p>Spike</p>
</def>
</def-item>
<def-item>
<term>UPLC</term>
<def>
<p>Ultra Performance Liquid Chromatography</p>
</def>
</def-item>
</def-list>
</glossary>
<sec sec-type="data-availability" id="S8">
<title>Data and Materials Availability</title>
<p id="P16">All data is available in the main text or the supplementary materials. Data, code and materials provided upon request.</p>
</sec>
<fn-group>
<fn id="FN1" fn-type="con">
<p id="P17">
<bold>Author Contributions:</bold> Conceptualization – P.V.R., N.K.T., P.A.M., G.S.A., P.J.B.; Funding acquisition – P.A.M; Investigation – P.V.R., N.K.T., F.S., X.Q., K.P., G.Y., M.M.K.; Methodology – P.V.R., N.K.T., F.S.; Resources – P.V.R., N.K.T., P.A.M., G.S.A., P.J.B.; Supervision &amp; Validation; Visualization – P.V.R., N.K.T., F.S.; Writing - original draft – P.V.R., N.K.T., G.S.A., F.S., P.J.B.; Writing – review &amp; editing - P.V.R., N.K.T., G.S.A., F.S., P.J.B., P.A.M.</p>
</fn>
<fn id="FN2" fn-type="conflict">
<p id="P18">
<bold>Competing interests:</bold> Authors declare no competing interests.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bar-Zeev</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Inglesby</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>COVID-19 vaccines: early success and remaining challenges</article-title>
<source>The Lancet</source>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corman</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Muth</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Niemeyer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Drosten</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Hosts and Sources of Endemic Human Coronaviruses</article-title>
<source>Adv Virus Res</source>
<year>2018</year>
<volume>100</volume>
<fpage>163</fpage>
<lpage>188</lpage>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>St-Jean</surname>
<given-names>JR</given-names>
</name>
<etal/>
</person-group>
<article-title>Human respiratory coronavirus OC43: genetic stability and neuroinvasion</article-title>
<source>J Virol</source>
<year>2004</year>
<volume>78</volume>
<fpage>8824</fpage>
<lpage>8834</lpage>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lau</surname>
<given-names>SKP</given-names>
</name>
<etal/>
</person-group>
<article-title>Coronavirus HKU1 and other coronavirus infections in Hong Kong</article-title>
<source>J Clin Microbiol</source>
<year>2006</year>
<volume>44</volume>
<fpage>2063</fpage>
<lpage>2071</lpage>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warnes</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Little</surname>
<given-names>ZR</given-names>
</name>
<name>
<surname>Keevil</surname>
<given-names>CW</given-names>
</name>
</person-group>
<article-title>Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials</article-title>
<source>mBio</source>
<year>2015</year>
<volume>6</volume>
<fpage>e01697</fpage>
<lpage>01615</lpage>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses</article-title>
<source>Trends Microbiol</source>
<year>2016</year>
<volume>24</volume>
<fpage>490</fpage>
<lpage>502</lpage>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersen</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Rambaut</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lipkin</surname>
<given-names>WI</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Garry</surname>
<given-names>RF</given-names>
</name>
</person-group>
<article-title>The proximal origin of SARS-CoV-2</article-title>
<source>Nat Med</source>
<year>2020</year>
<volume>26</volume>
<fpage>450</fpage>
<lpage>452</lpage>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Characterization of viral proteins encoded by the SARS-coronavirus genome</article-title>
<source>Antiviral Res</source>
<year>2005</year>
<volume>65</volume>
<fpage>69</fpage>
<lpage>78</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ke</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>Structures and distributions of SARS-CoV-2 spike proteins on intact virions</article-title>
<source>Nature</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lan</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor</article-title>
<source>Nature</source>
<year>2020</year>
<volume>581</volume>
<fpage>215</fpage>
<lpage>220</lpage>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<fpage>271</fpage>
<lpage>280.e278</lpage>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2</article-title>
<source>Science</source>
<year>2020</year>
<volume>367</volume>
<fpage>1444</fpage>
<lpage>1448</lpage>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walls</surname>
<given-names>AC</given-names>
</name>
<etal/>
</person-group>
<article-title>Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion</article-title>
<source>Proceedings of the National Academy of Sciences</source>
<year>2017</year>
<comment>201708727</comment>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vankadari</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence</article-title>
<source>The Journal of Physical Chemistry Letters</source>
<year>2020</year>
<volume>11</volume>
<fpage>6655</fpage>
<lpage>6663</lpage>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walls</surname>
<given-names>AC</given-names>
</name>
<etal/>
</person-group>
<article-title>Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<fpage>281</fpage>
<lpage>292 e286</lpage>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wrapp</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</article-title>
<source>Science</source>
<year>2020</year>
<volume>367</volume>
<fpage>1260</fpage>
<lpage>1263</lpage>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein</article-title>
<source>Nat Commun</source>
<year>2020</year>
<volume>11</volume>
<comment>3618</comment>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turonova</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges</article-title>
<source>Science</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>XX</given-names>
</name>
<etal/>
</person-group>
<article-title>Conformational changes in intact dengue virus reveal serotype-specific expansion</article-title>
<source>Nat Commun</source>
<year>2017</year>
<volume>8</volume>
<comment>14339</comment>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>XX</given-names>
</name>
<etal/>
</person-group>
<article-title>Epitope and Paratope Mapping Reveals Temperature-Dependent Alterations in the Dengue-Antibody Interface</article-title>
<source>Structure</source>
<year>2017</year>
<volume>25</volume>
<fpage>1391</fpage>
<lpage>1402 e1393</lpage>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vijayan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms</article-title>
<source>Scientific Reports</source>
<year>2020</year>
<volume>10</volume>
<comment>14214</comment>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>KK</given-names>
</name>
<etal/>
</person-group>
<article-title>Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2</article-title>
<source>Science</source>
<year>2020</year>
<volume>369</volume>
<fpage>1261</fpage>
<lpage>1265</lpage>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<etal/>
</person-group>
<article-title>Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<fpage>894</fpage>
<lpage>904.e899</lpage>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Wrapp</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McLellan</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Crispin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Site-specific glycan analysis of the SARS-CoV-2 spike</article-title>
<source>Science</source>
<year>2020</year>
<volume>369</volume>
<fpage>330</fpage>
<lpage>333</lpage>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions</article-title>
<source>Proceedings of the National Academy of Sciences</source>
<year>2020</year>
<volume>117</volume>
<fpage>13967</fpage>
<lpage>13974</lpage>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Farzan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Structure of SARS coronavirus spike receptor-binding domain complexed with receptor</article-title>
<source>Science</source>
<year>2005</year>
<volume>309</volume>
<fpage>1864</fpage>
<lpage>1868</lpage>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Towler</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis</article-title>
<source>J Biol Chem</source>
<year>2004</year>
<volume>279</volume>
<fpage>17996</fpage>
<lpage>18007</lpage>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry</article-title>
<source>PLOS Pathogens</source>
<year>2020</year>
<volume>16</volume>
<fpage>e1008392</fpage>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<boxed-text id="BX1" position="float" orientation="portrait">
<caption>
<title>One Sentence Summary</title>
</caption>
<p>SARS-CoV-2 spike protein binding to receptor ACE2 allosterically enhances furin proteolysis at distal S1/S2 cleavage sites</p>
</boxed-text>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>Structure and domain organization of trimeric S protein showing steps in the virus-host entry initiated by S recognition and binding to ACE2 receptor</title>
<p>
<bold>A.</bold> Prefusion S protein trimer in closed conformational state, with monomers shown in yellow, green and pink. S protein construct (1-1245) used in this study showing head, stalk and transmembrane (TM) segments as generated by integrative modeling. The S1/S2 and S2' cleavage sites are in red. Proteolytic processing (Furin) of S protein generates S1 and S2 subunits. <bold>B</bold>. Schematic of viral entry into host cell mediated by S:ACE2 interactions as previously outlined(<xref ref-type="bibr" rid="R28">28</xref>): (i) Intrinsic dynamics of pre-fusion S protein trimer decorating SARS-CoV-2 and host ACE2 dimeric structure showing sweeping motions of S protein and ACE2 to facilitate S:ACE2 recognition. (ii) In the open conformation (S<sub>open</sub>), RBD adopts an ‘up’ orientation to recognize and bind the host membrane-bound ACE2 receptor (PDB: 1R42). ACE2 binding induces conformational changes promoting Furin (red) proteolysis at the S1/S2 cleavage site (red arrows, leading to dissociation of S1 and S2 subunits, mechanism of which is unknown. (iii) The residual ACE2-bound S1 subunit stably bound to ACE2 and S2 subunits dissociate (iv) Conformational changes in the separated S2 subunit promote formation of an extended helical fusogenic intermediate (PDB ID: 6M3W),(<xref ref-type="bibr" rid="R17">17</xref>) for fusion into the host cell membrane, membrane fusion and viral entry into the host cell.(<xref ref-type="bibr" rid="R11">11</xref>)</p>
</caption>
<graphic xlink:href="EMS98602-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>Deuterium exchange heat map and MD simulations reveal domain-specific conformational dynamics of pre-fusion S protein trimer.</title>
<p>
<bold>A.</bold> Deuterium exchange heat map (shades of blue (low exchange) and red (high exchange)) of S protein (residues 1-1208) at t = 1 min deuterium exchange mapped onto structure of S protein. <bold>B.</bold> Per-residue root mean square fluctuations (RMSF) of the S protein (without TM domain) mapped on to the surface of the S trimer. Deuterium exchange based dynamics across N-terminal domain <bold>(C)</bold>, RBD <bold>(D)</bold>, and the S2 subunit <bold>(E)</bold>. (i) Relative fractional deuterium uptake (RFU) plots of NTD, RBD and the S2 subunit at 1 min (orange) and 10 min (black) deuterium exchange times is shown, with pepsin digest fragments displayed from N to C-terminus (X-axis), (see <xref ref-type="supplementary-material" rid="SD1">Fig. S2, Table S1</xref>). (ii) Close-up of the structures of NTD (21-303), RBD (318-552) and the S2 subunit (810-1208). Peptides spanning NTD-RBD interaction sites (166-182, 213-223, 294-303, 318-325, 375-387 and 442-449) showing relatively high deuterium exchange at t-=1 min are highlighted. (iii) The first principal motion and RMSF values of backbone atoms on the NTD, RBD and the S2 subunits. Residues with high RMSF are labelled. Different domains (FP, HR1, CH, CD, HR2) showing domain-specific RFU changes are labeled.</p>
</caption>
<graphic xlink:href="EMS98602-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>Map of RBD<sub>isolated</sub>:ACE2 interactions</title>
<p>
<bold>(A)</bold> Relative fractional deuterium uptake values at t = 1 min for RBD (314-547) of S protein (RBD<sub>S</sub>) mapped on to the structure of RBD extracted from S protein model (see <xref ref-type="supplementary-material" rid="SD1">Table S2</xref>). High and low exchanging regions are represented as shown in key, and regions with no coverage are shown in black. (<bold>B)</bold> The RMSF values of backbone atoms on the RBD showing residues with high RMSF (476-486), as per key. Differences in deuterium exchanged between RBD<sub>isolated</sub>:ACE2 complex and free RBD<sub>isolated</sub> <bold>(C)</bold> and RBD<sub>spike</sub>:ACE with free RBD<sub>spike</sub> <bold>(D)</bold> at 1min of deuterium labelling are mapped on to the structure of RBD. Protection from deuterium uptake and increases in exchange are indicated in blue and red respectively. Regions with no coverage are in black.</p>
</caption>
<graphic xlink:href="EMS98602-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<title>ACE2 interaction induce large scale allosteric changes across S protein</title>
<p>
<bold>(A)</bold> Differences in deuterium exchange (∆D<sub>ex</sub>) (t = 1 min) in S protein upon binding ACE2 showing decreased (blue) and increased (red) deuterium exchange, mapped onto structure of S protein. These differences in deuterium exchange for peptides from <bold>(B)</bold> RBD and S2 subunit <bold>(C)</bold> for pepsin digest fragments (X-axis) are shown. Difference cutoff ±0.3 D is the deuterium exchange significance threshold indicated by pink shaded box with standard error values in gray. Positive differences (&gt;0.3 D) denote increased deuterium exchange and negative differences (&lt;-0.3 D) denote decreased deuterium exchange in S protein bound to ACE2. <bold>(B)</bold>Peptides spanning residues interacting with ACE2 are in purple. <bold>(C)</bold> Peptides spanning fusion peptide (FP) and HR1 are highlighted in pink boxes, while peptides spanning central helix (CH) and heptad repeat 2 (HR2) are in blue. <bold>D.</bold> Stacked mass spectra with isotopic envelopes after deuterium exchange (t = 1, 10 min) for select peptides from (i) RBD (residues 476-498), (ii) S1/S2 cleavage site (residues 672-690), (iii) fusion peptide (residues 823-832) and (iv) HR2 (residues 1175-1188) are shown for the S protein and S:ACE2 complex. Mass spectra of the equivalent undeuterated peptide are shown for reference. The centroid masses are indicated by red arrow-heads.</p>
</caption>
<graphic xlink:href="EMS98602-f004"/>
</fig>
</floats-group>
</article>
